Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D

OBJECTIVE: To evaluate the efficacy and safety of ultra rapid lispro (URLi) versus lispro in patients with type 2 diabetes on a basal-bolus insulin regimen. RESEARCH DESIGN AND METHODS: This was a phase 3, treat-to-target, double-blind 26-week study. After an 8-week lead-in to optimize basal insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Blevins, Thomas, Zhang, Qianyi, Frias, Juan P., Jinnouchi, Hideaki, Chang, Annette M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770265/
https://www.ncbi.nlm.nih.gov/pubmed/32616612
http://dx.doi.org/10.2337/dc19-2550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770265/
https://www.ncbi.nlm.nih.gov/pubmed/32616612
http://dx.doi.org/10.2337/dc19-2550

Ejemplares similares